AsiaMedic to acquire LuyeEllium Healthcare for S$42.2 million
ASIAMEDIC has entered into a conditional sale and purchase agreement with the shareholders of LuyeEllium Healthcare to acquire the company for S$42.2 million.
LuyeEllium provides hospital management services to hospitals in South Korea and China.
The consideration will be fulfilled via the issuance of 527.1 million new shares, at the issue price of eight Singapore cents per share.
Upon completion of the proposed acquisition, it will be a wholly owned subsidiary of the AsiaMedic.
AsiaMedic will be appointing an independent valuer to prepare a valuation report on LuyeEllium.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Indian banks to step up IT spends as regulatory scrutiny rises
Puma returns to sales growth in Americas despite ‘volatile’ market
Shell to sell Singapore oil refinery, chemicals assets to Glencore joint venture
AstraZeneca lifts FTSE 100 to record high
Amazon breaks into Europe 5G networks with Telefonica cloud deal
Nanjing Xinjiekou Department Store announces May 23 EGM; Cordlife seeking legal advice